Azitra, Inc. (NYSEAMERICAN:AZTR – Get Free Report)’s share price fell 1.1% during trading on Friday . The company traded as low as $0.55 and last traded at $0.55. 111,676 shares were traded during trading, a decline of 89% from the average session volume of 1,012,930 shares. The stock had previously closed at $0.56.
Azitra Stock Down 1.1 %
The company has a debt-to-equity ratio of 0.01, a quick ratio of 0.77 and a current ratio of 0.77.
Azitra (NYSEAMERICAN:AZTR – Get Free Report) last issued its quarterly earnings results on Monday, August 12th. The company reported ($2.74) EPS for the quarter, missing analysts’ consensus estimates of ($2.59) by ($0.15). The business had revenue of $0.01 million for the quarter. Azitra had a negative return on equity of 278.76% and a negative net margin of 1,644.90%. Equities research analysts anticipate that Azitra, Inc. will post -3.06 earnings per share for the current year.
Azitra Company Profile
Azitra, Inc, an early-stage biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease.
Read More
- Five stocks we like better than Azitra
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Can Costco Stock Hit New Highs as Interest Rates Drop?
- The Basics of Support and Resistance
- These 3 Stocks Show How to Navigate Declining Consumer Confidence
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- MicroStrategy’s Returns Are 3X Higher Than Bitcoin: Time to Buy?
Receive News & Ratings for Azitra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azitra and related companies with MarketBeat.com's FREE daily email newsletter.
